Oxprenolol 20mg tablets

Land: Storbritannien

Språk: engelska

Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiva substanser:

Oxprenolol hydrochloride

Tillgänglig från:

Advanz Pharma

ATC-kod:

C07AA02

INN (International namn):

Oxprenolol hydrochloride

Dos:

20mg

Läkemedelsform:

Oral tablet

Administreringssätt:

Oral

Klass:

No Controlled Drug Status

Receptbelagda typ:

Valid as a prescribable product

Produktsammanfattning:

BNF: 02040000

Bipacksedel

OXPRENOLOL 20 MG, 40 MG AND 80 MG TABLETS
OXPRENOLOL HYDROCHLORIDE
GB 727-0382-APIL
SOVEREIGN
M
E
D
I
C
A
L
READ ALL OF THIS LEAFLET CAREFULLY
BEFORE YOU START TAKING THIS
MEDICINE.
-
Please keep this leaflet. You may
need to read it again.
-
If you have any further questions,
ask your doctor or pharmacist.
-
This medicine has been prescribed
for you. Do not pass it on to others.
It may harm them, even if their
symptoms are the same as yours.
-
If any of the side effects becomes severe, or if you notice any
side effects not listed in this leaflet, please tell your doctor or
pharmacist.
IN THIS LEAFLET:
1.
What Oxprenolol Tablets are and what they are used for
2.
Before you take Oxprenolol Tablets
3.
How to take Oxprenolol Tablets
4.
Possible side effects
5.
How to store Oxprenolol Tablets
6.
Further information
1.
WHAT OXPRENOLOL TABLETS ARE AND WHAT THEY ARE
USED FOR
The name of your medicine is Oxprenolol 20 mg, 40 mg or 80 mg
Tablets.
Oxprenolol
Tablets
contain
the
active
ingredient
oxprenolol
hydrochloride.
Oxprenolol hydrochloride belongs to a group of medicines called
beta-blockers.
Oxprenolol is used to treat high blood pressure and to reduce or
prevent chest pain (angina). It is also used to treat some heart
disorders such as irregular heart beat and to relieve the symptoms
of anxiety.
2.
BEFORE YOU TAKE OXPRENOLOL TABLETS
DO NOT TAKE OXPRENOLOL TABLETS IF YOU:
•
are ALLERGIC to OXPRENOLOL, any other beta-blockers, or any of
the other ingredients of Oxprenolol Tablets (allergic reactions
include mild symptoms such as itching and/or rash. More
severe symptoms include swelling of the face, lips, tongue
and/or throat with difficulty in swallowing or breathing);
•
have a history of asthma or wheezing attacks;
•
have any HEART problems (e.g. heart failure, cardiogenic
shock);
•
have an untreated TUMOUR of the adrenal gland
(phaeochromocytoma);
•
have any heart rhythm disorders (sick-sinus syndrome);
•
have a very LOW PULSE RATE (less than 50 beats per minute);
•
have Prinzmetal’s angina (a spec

Produktens egenskaper

OBJECT 1
OXPRENOLOL 20 MG TABLETS
Summary of Product Characteristics Updated 08-Feb-2017 | ADVANZ Pharma
•
1. Name of the medicinal product
•
2. Qualitative and quantitative composition
•
3. Pharmaceutical form
•
4. Clinical particulars
•
4.1 Therapeutic indications
•
4.2 Posology and method of administration
•
4.3 Contraindications
•
4.4 Special warnings and precautions for use
•
4.5 Interaction with other medicinal products and other forms of
interaction
•
4.6 Fertility, pregnancy and lactation
•
4.7 Effects on ability to drive and use machines
•
4.8 Undesirable effects
•
4.9 Overdose
•
5. Pharmacological properties
•
5.1 Pharmacodynamic properties
•
5.2 Pharmacokinetic properties
•
5.3 Preclinical safety data
•
6. Pharmaceutical particulars
•
6.1 List of excipients
•
6.2 Incompatibilities
•
6.3 Shelf life
•
6.4 Special precautions for storage
•
6.5 Nature and contents of container
•
6.6 Special precautions for disposal and other handling
•
7. Marketing authorisation holder
•
8. Marketing authorisation number(s)
•
9. Date of first authorisation/renewal of the authorisation
•
10. Date of revision of the text
1. Name of the medicinal product
Trasicor 20 mg Tablets.
Oxprenolol 20 mg Tablets.
2. Qualitative and quantitative composition
Each tablet contains 20 mg of oxprenolol hydrochloride.
Excipients with known effect:
Sucrose
powder
(86 mg/tablet)
(39.6 mg/tablet)
Wheat starch
For the full list of excipients, see section 6.1
3. Pharmaceutical form
Film-coated tablets.
White, round, biconvex, film-coated tablets, impressed OXP 20 on one
face and no marking on the other.
4. Clinical particulars
4.1 Therapeutic indications
Trasicor Tablets are indicated in adults for the treatment of:
Angina Pectoris: For long-term prophylactic use (if necessary nitrates
should be employed for alleviating
acute attacks).
Hypertension: As monotherapy or for use in combination with other
antihypertensives, e.g. with a
diuretic, peripheral vasodilator, calcium channel blocker or A